These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38497281)

  • 1. Efficacy and Safety of JAK-Inhibitors in Treating Refractory Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis: A Systematic Review.
    Rijal H; Bouadi N; Dahlke E; Litvinov IV
    J Cutan Med Surg; 2024; 28(3):299-301. PubMed ID: 38497281
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation.
    Koga T; Sato T; Umeda M; Fukui S; Horai Y; Kawashiri SY; Iwamoto N; Ichinose K; Nakamura H; Kawakami A
    Clin Immunol; 2016 Dec; 173():147-148. PubMed ID: 27720846
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of refractory palmoplantar psoriasis in a psoriatic arthritis patient with the JAK inhibitor tofacitinib.
    Valor-Méndez L; Sticherling M; Kleyer A; Schett G
    Clin Exp Rheumatol; 2021; 39(1):228. PubMed ID: 32828149
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Janus Kinase Inhibitor Treatment for Palmoplantar Pustulosis: An Evidence-Based Review.
    Sood S; Abduelmula A; Maliyar K; Georgakopoulos JR; Mufti A; Vender R; Prajapati VH; Yeung J
    J Cutan Med Surg; 2024; 28(1):86-87. PubMed ID: 37937880
    [No Abstract]   [Full Text] [Related]  

  • 5. JAK inhibitors in chronic plaque psoriasis: What is known so far.
    Plachouri KM; Georgiou S
    Drugs Today (Barc); 2020 Feb; 56(2):151-163. PubMed ID: 32163530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome.
    Li C; Li Z; Cao Y; Li L; Li F; Li Y; Xiong D; Wu X; Zhang W; Zeng X
    JAMA Dermatol; 2021 Jan; 157(1):74-78. PubMed ID: 32997094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarity and difference between palmoplantar pustulosis and pustular psoriasis.
    Yamamoto T
    J Dermatol; 2021 Jun; 48(6):750-760. PubMed ID: 33650702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic.
    Gleeson D; Barker JNWN; Capon F; Pink AE; Woolf RT; Smith CH; Mahil SK
    Br J Dermatol; 2023 Mar; 188(4):471-473. PubMed ID: 36715624
    [No Abstract]   [Full Text] [Related]  

  • 9. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
    Sanchez IM; Sorenson E; Levin E; Liao W
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HL-A antigens in patients with persistent palmoplantar pustulosis and pustular psoriasis.
    Karvonen J; Tiilikainen A; Lassus A
    Ann Clin Res; 1975 Apr; 7(2):112-5. PubMed ID: 1181975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature.
    Samadi A; Ahmad Nasrollahi S; Hashemi A; Nassiri Kashani M; Firooz A
    J Dermatolog Treat; 2017 Sep; 28(6):476-483. PubMed ID: 28024126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of tofacitinib, peficitinib, solcitinib, baricitinib, abrocitinib and deucravacitinib in plaque psoriasis - A network meta-analysis.
    Zhang L; Guo L; Wang L; Jiang X
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):1937-1946. PubMed ID: 35608188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature.
    Salman A; Sarac G; Ergun T
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report.
    Haynes D; Topham C; Hagstrom E; Greiling T
    Australas J Dermatol; 2020 Feb; 61(1):e108-e110. PubMed ID: 31318041
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparing available JAK inhibitors for treating patients with psoriasis.
    Funk PJ; Perche PO; Singh R; Kelly KA; Feldman SR
    Expert Rev Clin Immunol; 2022 Mar; 18(3):281-294. PubMed ID: 35129030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.
    Saeki H; Mabuchi T; Asahina A; Abe M; Igarashi A; Imafuku S; Okubo Y; Komine M; Takahashi K; Torii H; Morita A; Yotsuyanagi H; Watanabe A; Ohtsuki M;
    J Dermatol; 2023 May; 50(5):e138-e150. PubMed ID: 37132187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    Chen CY; Chen WC; Hsu CK; Chao CM; Lai CC
    Int Immunopharmacol; 2021 Oct; 99():108027. PubMed ID: 34343937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis.
    Huang IH; Wu PC; Chiu HY; Huang YH
    Am J Clin Dermatol; 2024 May; 25(3):347-358. PubMed ID: 38438782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients.
    Xiaoling Y; Dan S; Hongzhong J
    An Bras Dermatol; 2019; 94(6):658-663. PubMed ID: 31789248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series.
    Xu Q; Wang X; Yang A; Wei G
    Infect Drug Resist; 2023; 16():5165-5172. PubMed ID: 37581169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.